Our Management Team
With a distinguished career at STAGO spanning over 35 years, Philippe Baroux has been instrumental in the organization's success and growth. His extensive tenure has allowed him to develop deep, cross-functional expertise across numerous disciplines, including Sales, Marketing, M&A, Finance, HR, Regulatory Affairs, Quality Assurance, Supply Chain, and Manufacturing for both Central Laboratory and Point-of-Care (POC) businesses.
For over 15 years, Mr. Barroux has leveraged his expertise to lead and expand STAGO's operations in France, the USA, and China, successfully growing the latter into the organization's second-largest market globally. This international experience, combined with mentorship from STAGO’s Leadership Team, has shaped his open-minded and inclusive leadership approach that resonates across cultures and teams.
His considerable background in the Point of Care (POC) sector has provided him with invaluable insight into the needs of the market, which he now applies to drive the HemoSonics brand forward. Philippe Baroux is committed to fostering the continued success and growth of both STAGO and HemoSonics, LLC..
Francesco Viola, PhD, has more than 10 years of experience in the area of medical ultrasound imaging, advanced signal processing and development of medical instrumentation.
Viola has published his research in numerous engineering and biomedical peer-reviewed journals and he is the co-inventor in a number of patents in the field of ultrasound imaging and sensing. He is also the first recipient of The Emerging Technologies and Healthcare Innovations Congress (TETHIC) Award for achievements in scholarship and contributions to healthcare technology translation. Viola holds a Laurea in Biomedical Engineering from the Polytechnic University of Milan, Italy, and a PhD in Biomedical Engineering from the University of Virginia.
Raymond L Szafranski Jr (Ray) has more than 30 years of finance and accounting experience as well as manufacturing, human resources, and operations.
Prior to HemoSonics, he was VP of Finance for Panacea Biomatx, manufacturer of personalized nutrition from 2014-2020. Before that, he held various positions in Finance in industries such as pharmaceutical manufacturing, personalized nutrition, and laboratory robotics. Szafranski earned an Accounting degree from the University of Notre Dame and an MBA from Duke University. He is also a Certified Public Accountant (NC License) and Certified Management Accountant.
Andy Suresh brings over 20 years of experience in leading Operations and Supply Chain within the Medical Device industry. He has contributed to the success of a number of medical device start-ups/early commercial companies, leading the transition of products from design to manufacturing and commercialization. He has also led the successful transition of manufacturing and Supply Chain processes into scalable enterprises. Additionally, Andy is committed to continuous improvement, lean initiatives, and waste reduction, all aimed at enhancing process efficiency and profitability. His customer-focused, servant leadership style has consistently empowered teams and driven success.
Andy holds a Master’s degree in industrial engineering and a Bachelor's degree in Mechanical Engineering.
Deborah Winegar has more than 20 years of experience managing clinical and discovery research efforts at a variety of healthcare, medical device and pharmaceutical organizations.
She has led multi-disciplinary project teams focused on the discovery and development of therapeutic agents, biomarkers and diagnostic products in the cardiovascular and metabolic disease areas. Prior to joining HemoSonics, Winegar served in multiple roles at GlaxoSmithKline, as Director of Research at Surgical Review Corporation and as Senior Director of Clinical Trials at LipoScience. She earned a Bachelor of Science degree in Chemistry from Notre Dame College and a PhD in Biochemistry from the University of Virginia.
Thomas Givens has 30 years of experience leading interdisciplinary engineering teams and developing medical devices.
He has developed in vitro diagnostic devices based on a variety of detection technologies for multiple clinical laboratory areas. Givens earned a Bachelor of Science in Biomedical Engineering from The University of Tennessee and a Masters of Science in Mechanical Engineering from Duke University.
Joe has more than 25 years of experience leading world-class medtech sales and marketing organizations focused on helping hospitals, clinicians, and clinical teams adopt advanced technology and improve the clinical experience and clinical outcomes. As Head of the US Commercial organization, he oversees the company’s capital sales, clinical support, marketing, and customer success teams.
Prior to joining HemoSonics, Joe served in roles of increasing responsibility with Medtronic, Johnson & Johnson, Boston Scientific, and Smith & Nephew from 1998-2020. Joe earned his Bachelor of Science in Business Administration, with a concentration in Finance at Fordham University’s Gabelli School of Business.
Explore the System
Learn more about the features of our next-gen device designed for the POC and how it empowers clinicians to quickly assess coagulation characteristics.
Explore Scientific Publications
See articles on clinical studies and sonorheometry as well as the full list of guidelines calling for point-of-care coagulation analysis.